Bispecific Monoclonal Antibodies and CAR T-Cell Therapy in Multiple Myeloma, Omar Nadeem, MD Published 2022-01-19 Download video MP4 360p Download video MP4 720p Recommendations 1:02:04 The Power of Resilience 1:11:38 Exercise, Heat, Cold & Other Stressors for Longevity | Lifespan with Dr. David Sinclair #3 23:13 Bispecific Antibodies in Multiple Myeloma | Dana-Farber Cancer Institute 49:36 Multiple Myeloma Precursor Conditions | Overview | Therapeutic Intervention 14:05 B cell Activaiton And Differentiation 38:40 Bispecific antibodies in lymphoma: an update 27:54 "Cerebral Edema in Diabetic Ketoacidosis" by Michael Agus, MD for OPENPediatrics 26:57 DCIS - A Pathologist's Perspective | 2023 Ductal Carcinoma In Situ Patient Forum 05:44 Bispecific Antibodies: Early Side Effects 1:08:32 Treating Lymphoma with Bispecific Antibodies | LRF Webinars 37:38 Learn the Basics of Immunotherapy from David Reardon, M.D. 24:10 Dr. Maryanne Demasi - 'Statin Wars: Have we been misled by the evidence?' 12:16 Isotype switching | class switching recombination | Antibody class switching | antibody diversity 59:58 Long-Term Side Effects of Brain Tumor Treatment 33:04 Lecture 10c: Cancer Immunotherapy 04:45 Bispecifics Part 2: Monoclonal and Bispecific Antibodies 1:28:26 Cancer Metabolism: From molecules to medicine 07:07 Immunology - Introduction to Antibodies 02:44 How is Immunotherapy Used to Fight Cancer? | Dana-Farber Cancer Institute | Science Illustrated 01:36 Bispecific T-Cell Engagers (BiTEs) as Treatment of B-Cell Lymphoma Similar videos 07:15 Evolving Myeloma Treatment Options | Bispecific Antibody Therapy 04:28 Evolving Myeloma Treatment Options | CAR T-Cell Therapy 01:27 The value of bispecifics in myeloma & the importance of optimally sequencing immunotherapies 02:27 BMS-986393, a novel anti-GPRC5D CAR-T cell therapy, in multiple myeloma 30:43 Evolving Myeloma Treatment Options: How You Can Access Cutting-Edge Care 03:13 Next Generation Myeloma Treatment Options 02:31 What Are Currently Available Myeloma Treatments? 31:00 CAR T-Cells Multiple Myeloma: Adam Sperling, MD, PhD 02:47 How Could Clinical Trials Fit Into Your Myeloma Treatment Plan? 57:20 Know Your Myeloma Immunotherapy: Bispecific Antibodies with Dr. Cesar Rodriguez 01:23 Investigating bispecific antibodies in high-risk smoldering myeloma: the ImmunoPRISM platform study 04:40 Clinical Trials for Myeloma Treatment | Essential Information for Patients 01:20 A comparison of bispecific antibodies emerging in multiple myeloma 02:22 Combining CAR-Ts & bispecific antibodies 1:02:15 When and How You Become Refractory to a Drug and How to Find the Best Next Treatment 04:35 Bispecifics Part 3: Pros and Cons of Bispecifics 03:03 The future of CAR-T therapy for multiple myeloma 03:54 Highlights in multiple myeloma from ASH 2021: cilta-cel, bispecific antibodies & disease biology More results